Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Nazia Khan, MD is a hematologist and oncologist with Atlantic Medical Group, overseeing the Atlantic Medical Group Bridgewater Pavilion Infusion Center. She is board certified in internal medicine, medical oncology and hematology, and fellowship-trained in hematology and oncology. Dr. Khan treats a wide range of cancers and blood disorders and helps patients cope with the challenges these illnesses may present to multiple systems in the body. Using an evidence-based approach to patient care, she employs state-of-the-art treatment protocols in collaboration with other specialists to help patients manage their illness and achieve a better quality of life. In her role as director of the infusion center, she oversees outpatient treatments including intravenous chemotherapy, immunotherapy, and biotherapy, providing patients with access to the leading-edge cancer treatments in a caring and safe environment. Dr. Khan participates in ongoing clinical trials and is dedicated to teaching medical students and residents and fellows the principles of hematology/oncology. She has served as an adjunct clinical assistant professor at Touro College of Osteopathic Medicine, NY, and is an active faculty member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Khan is originally from India where she attended the Maulana Azad Medical College in New Delhi. She came to the United States to pursue a residency at Seton Hall University School of Health and Sciences, Trinitas Regional Medical Center, NJ, and a fellowship at New York Medical College/St. Joseph’s University Medical Center, NJ. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Lymphofollicular Hyperplasia, Malignant Peripheral Nerve Sheath Tumor, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.

Jeanette Kovtun is an Internal Medicine provider in Florham Park, New Jersey. Dr. Kovtun is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Mesothelioma, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Thrombocytopenia. Dr. Kovtun is currently accepting new patients.

Sophie Morse is a Hematologist Oncology specialist and a Hematologist in Summit, New Jersey. Dr. Morse is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer.

Jason Levitz is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Levitz is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS).

Heather Katz, DO, FACOI, FACP, is a board-certified hematologist and medical oncologist specializing in the diagnosis and treatment of solid tumors and hematologic malignancies. Her clinical expertise includes cancers of the breast, gastrointestinal tract, head and neck, genitourinary system, lung, and gynecologic organs, as well as hematologic conditions such as leukemia, lymphoma, and multiple myeloma. Dr. Katz is committed to delivering comprehensive, evidence-based care grounded in compassion and respect for each patient’s individual journey. She emphasizes shared decision-making, continuity of care, and clear communication to empower patients and their families throughout treatment and survivorship. Dr. Katz earned her Bachelor of Science in Biology, with a minor in Human Development, from the State University of New York at Geneseo. She received her medical degree from Rocky Vista University College of Osteopathic Medicine in Parker, Colorado, and completed her internal medicine residency at Broward Health Medical Center in Fort Lauderdale, Florida, where she served as Chief Resident and was named Resident of the Year. She went on to complete her fellowship in Hematology and Medical Oncology at Marshall University’s Joan C. Edwards School of Medicine in Huntington, West Virginia, serving as Chief Fellow in her final year. Board certified in Internal Medicine, Medical Oncology, and Hematology by the American Osteopathic Board of Internal Medicine, Dr. Katz is a Fellow of both the American College of Osteopathic Internists and the American College of Physicians. She has presented at numerousnational oncology conferences and is the author of over 15 peer-reviewed publications in the medical literature. Dr. Katz is dedicated not only to clinical excellence but also to advancing the field of oncology through research, education, and mentorship. Her patients recognize her for her thoughtful bedside manner, personalized treatment planning, and unwavering commitment to high-quality care. . Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Salpingo-Oophorectomy.

Naveed Jan is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Jan is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, and Vitamin B12 Deficiency. Dr. Jan is currently accepting new patients.

Christopher Tully is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Tully is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Lung Cancer. Dr. Tully is currently accepting new patients.

Fazal Bari is a Hematologist and an Oncologist in Mountain Lakes, New Jersey. Dr. Bari is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Colorectal Cancer. Dr. Bari is currently accepting new patients.

John Forward is a primary care provider, practicing in Internal Medicine in Dover, New Jersey. Dr. Forward is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and High Cholesterol. Dr. Forward is currently accepting new patients.

Unnati Tailor is a primary care provider, practicing in Family Medicine in Chester, New Jersey. Dr. Tailor is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Sinusitis, Obesity, Empyema, and Premature Ovarian Failure. Dr. Tailor is currently accepting new patients.

Deborah Neiman is a primary care provider, practicing in Internal Medicine in Bedminster, New Jersey. Dr. Neiman is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Vitamin D Deficiency, Nonsyndromic Hearing Loss, Cerebellar Degeneration, and Infant Hyperglycemia. Dr. Neiman is currently accepting new patients.

Beata Pieczara is a Hematologist and an Oncologist in Pompton Plains, New Jersey. Dr. Pieczara is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Inflammatory Breast Cancer, Lynch Syndrome, and Bone Marrow Aspiration. She is board certified in American Board Of Internal Medicine. Dr. Pieczara is currently accepting new patients.

Harish Shah is a Hematologist Oncology specialist and a Hematologist in Wayne, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Essential Thrombocythemia, Febrile Neutropenia, Agranulocytosis, and Chronic Familial Neutropenia.